Find More Contacts for Semprus BioSciences
Protected Content
Health Professional
Director Operations
2 emails found
View contacts for Semprus BioSciences to access new leads and connect with decision-makers.
View All Contacts
  • Contact Email info@semprusbio.com
  • Phone Number 6175777756

Semprus BioSciences is a venture-backed biomedical company headquartered in Cambridge, Massachusetts. Our innovative, multi-faceted Semprus technology signifies a breakthrough in medical device technology. Our current focus is to develop a vascular access catheter with the first single surface modification that is designed to simultaneously reduce

microbial adherence and thrombus accumulation over the life of the device. In December 2010, the company completed an $18 million Series B financing co-led by SR One, the corporate venture capital arm of GlaxoSmithKline, and Foundation Medical Partners (FMP), a national healthcare venture capital investment firm with a strategic relationship with Cleveland Clinic. Combined with previous financing rounds, Semprus has raised a total of $28.5 million in equity.

Lists Featuring This Company

Northeastern US Companies that Exited (Top 10K)
9,925 Number of Organizations • $831.9B Total Funding Amount • 24,429 Number of Investors
Acquired Northeastern US Companies (Top 10K)
9,943 Number of Organizations • $254.9B Total Funding Amount • 20,106 Number of Investors
Closed East Coast Health Care Companies
2,506 Number of Organizations • $25.7B Total Funding Amount • 2,114 Number of Investors
Closed Massachusetts Companies
3,410 Number of Organizations • $35.7B Total Funding Amount • 4,588 Number of Investors
on Jun 25, 2012.

Frequently Asked Questions

Where is Semprus BioSciences's headquarters? Semprus BioSciences is located in Cambridge, Massachusetts, United States.Who invested in Semprus BioSciences? Semprus BioSciences has 5 investors including Pangaea Ventures and Foundation Medical Partners.How much funding has Semprus BioSciences raised to date? Semprus BioSciences has raised .When was the last funding round for Semprus BioSciences? Semprus BioSciences closed its last funding round on Oct 19, 2011 from a Grant round.Who are Semprus BioSciences's competitors? Alternatives and possible competitors to Semprus BioSciences may include Immutrix Therapeutics and Thinks Works.